In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

King to buy Medco Research in $314mm stock swap

Executive Summary

King Pharmaceuticals (niche pharmaceuticals) is buying Medco Research (adenosine-based therapeutics) in a stock swap, pooling of interest transaction that values Medco at $314mm. Each Medco common share will be exchanged for King common worth $30, a (pr)12% premium to the market average. Terms include a collar, and the ratio will be adjusted if King's trading price falls below $33 or above $49.87.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register